MUSTANG BIO, INC. — Director's Dealing 2021

Jul 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MUSTANG BIO, INC. (MBIO)
CIK: 0001680048
Period of Report: 2021-06-28

Reporting Person: WEISS MICHAEL S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-28	COMMON STOCK	A	13774	—	Acquired	64197	Indirect

Footnotes

F1: 13,774 restricted shares were granted pursuant to the Issuer's 2016 Incentive Plan on June 28, 2021. The shares will vest on June 17, 2024, subject to the Reporting Person's continued service on the Issuer's board on such date.

F2: Includes restricted share units, which vest over various time periods.

F3: The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member.